Chemours reported a strong second quarter in 2021, with net sales of $1.7 billion, a 51% increase year-over-year. Net income was $66 million, with an EPS of $0.39. Adjusted EBITDA was $366 million, up 120% year-over-year, and free cash flow was $189 million, an increase of $139 million year-over-year.
Net Sales of $1.7 billion, up 51% year-over-year
Net Income of $66 million with EPS of $0.39
Adjusted Net Income of $205 million with Adjusted EPS of $1.20, up $1.02 year-over-year
Free cash flow of $189 million, an increase of $139 million year-over-year
Given strong second quarter results and continued business momentum, Chemours now expects 2021 Adjusted EBITDA and Adjusted EPS to be in the top end of its guidance ranges.